Bridging Financial, Clinical & Operational Processes for Optimal Outcomes

Coding • CDI • Denial Management • Risk Adjustment • PSI

Program Design, Implementation & Optimization   • Assessments & Audits   • Staffing & Managed Services   • Education & Training

Learn more

Expertise in Enhancing Revenue, Efficiency, Operations and Compliance for Healthcare Systems

40+ Years

Proven track record in revenue cycle management

1100 +

Hospital Facilities and Physician Groups Nationwide

540

Credentialed Consultants & Staff

96% +

Coding accuracy based on 3rd party audits

A sticker that says best in klas outsourced coding

Top 3 Best in KLAS for outsourced coding for past 8 years

UASI is Trusted by 1100+ Hospital Facilities and Physician Groups Nationwide


Our Solutions

Mid-Rev Cycle  Solutions that Work

A line drawing of a graph on a white background.

Program Design, Implementation and Optimization

Our pragmatic approach targets specific opportunities to enhance standards, fiscal objectives, and regulatory compliance, thereby boosting performance and fortifying outcomes.

LET'S GO!
A black and white drawing of a window on a white background.

Assessments and
Audits

Achieve higher quality outcomes and an attainable ROI with ongoing and strategic audits and reviews of your operation.

LET'S GO!
A black and white drawing of a stack of squares on a white background.

Education and Training

We facilitate the shift to value-based care with expert support in people, processes, and technology, offering a measured approach for quick ROI and scalable success.

LET'S GO!

Staffing and Managed Services

Achieve coding, CDI, or revenue integrity staffing flexibility with confidence, surpassing accuracy, quality, and productivity goals through our tiered support model.

LET'S GO!

Health in Context: Understanding the Impact of Social Determinants of Health (SDoH)


Summary of a Presentation by Rachel Mack, MSN, RN, CCDS, CDIP, CCS, CRC at the 2025 CHIMA Annual Meeting

In this must-read article, you will:


Uncover how Social Determinants of Health (SDoH) like housing, food access, and education drive health outcomes beyond clinical care.


Reveal the real-world effects of SDoH on chronic illness, health disparities, and population-level risks.


Demystify the power of ICD-10-CM Z codes in capturing and addressing social needs in medical records.


Break down the nine Z code categories that illuminate a patient’s lived experience and care barriers.


Tackle the documentation challenges and discover innovative solutions that support equitable, data-informed care.


Download the FULL ARTICLE 

for INSTANT ACCESS

A black and white silhouette of a quote on a white background.

“I have worked with UASI for many years, they are my go to for CDI. UASI provides experienced CDI staffing resources as well great products with their CDI assessment and their customizable CDI audits. Partnering with UASI is helping our CDI team continuously grow and improve.”

- Tallahassee Memorial Healthcare

Our Services

Discover a comprehensive range of healthcare solutions designed to optimize revenue, enhance compliance, and improve operational efficiency. From coding and CDI to risk-based services and revenue integrity, UASI provides expert support to meet your unique needs.

A silhouette of two arrows pointing in opposite directions on a white background.

CODING SERVICES

Achieve accurate, compliant, and efficient coding with our professional coding services, supporting inpatient (IP), outpatient (OP), professional fee (Profee), home health, and ambulance coding needs with UASI.

LEARN MORE
A black and white silhouette of a light bulb on a white background.

RISK BASED SERVICES

At UASI, we optimize your risk adjustment and value-based care initiatives with our specialized risk-based services, ensuring accurate coding and improved financial outcomes.

LEARN MORE
A black arrow pointing to the right on a white background.

CDI SERVICES

UASI enhances the accuracy and completeness of your clinical documentation, ensuring compliance and optimal reimbursement through our expert CDI services.

LEARN MORE
A black and white drawing of a megaphone on a white background.

DENIALS & REVENUE INTEGRITY

Maintain financial health and compliance with UASI's comprehensive revenue integrity services, including auditing, denials management, and process optimization.

LEARN MORE

Explore our INSIGHTS section for valuable resources, including articles, results, whitepapers, case studies, and more. Stay informed and gain expert knowledge to drive your healthcare organization's success with UASI.

By Katie Curry September 16, 2025
Why CMS Star Ratings Matter More Than Ever Hospitals are constantly measured on their quality of care, but few metrics carry as much weight as the Centers for Medicare & Medicaid Services (CMS) Star Ratings. These ratings influence how patients choose hospitals, how payers negotiate contracts, and how organizations position themselves in an increasingly competitive healthcare landscape. The Role of Star Ratings The CMS Star Ratings program evaluates hospitals across a wide range of quality measures. These include clinical outcomes such as readmissions and mortality, safety indicators like hospital-acquired conditions, and patient experience surveys addressing communication, responsiveness, and cleanliness. Hospitals receive an overall score that is highly visible to the public and payers. Impact on Patient Choice and Public Perception Patients want assurance that the care they receive will be safe and effective. Star Ratings serve as a shorthand for quality, guiding patient choice when selecting where to receive treatment. Hospitals with higher ratings often enjoy stronger reputations in their communities, while lower ratings can raise concerns about safety and performance. Influence on Reimbursement and Contracts Star Ratings are not just symbolic. They affect how hospitals are reimbursed, influence payer negotiations, and may unlock incentive payments for high performance. For many organizations, Star Ratings directly shape financial sustainability and the ability to reinvest in staff and technology. The Hidden Impact of Denials on Star Ratings Denials are often seen as a revenue cycle issue, but their impact goes far beyond delayed payments. When denials distort clinical data, they also undermine a hospital’s performance in CMS Star Ratings. Financial Consequences Every denied claim represents lost or delayed revenue. This directly reduces the resources available for quality initiatives, staffing, and patient experience improvements. Hospitals under financial strain may struggle to invest in areas that strengthen Star Ratings. Data Accuracy and Risk Adjustment Denials linked to documentation gaps or coding errors can lead to underreporting of patient complexity. Missed severity of illness and comorbidities affect risk adjustment, making outcomes such as mortality or readmissions appear worse than they are. Inaccurate data paints an incomplete picture of care quality. Denials influence critical Star Ratings measures, including: Mortality rates Readmission rates Complications Patient safety indicators When denials obscure true performance, hospitals risk lower ratings despite providing high-quality care. Operational Burden Staff rework and appeals consume time that could otherwise be dedicated to patient care, CDI initiatives, and proactive quality improvements. This operational distraction further hampers performance on Star Ratings measures. Organizations that do not address denial management place both their financial health and their public reputation at risk. By taking a proactive and comprehensive approach to denial prevention and management, hospitals can improve patient outcomes, protect vital revenue streams, and reinforce the trust and confidence of their communities and stakeholders. Turning Denial Prevention into Star Ratings Success Reducing denials is about more than revenue recovery. It is a strategic opportunity to strengthen documentation, improve data accuracy, and ultimately elevate CMS Star Ratings. Key Risks to Address Hospitals that do not proactively manage denials face three major risks: Missed capture of severity of illness and risk adjustment Underreported quality outcomes Reduced ability to invest in staff, technology, and patient experience Strategic Priorities for Hospitals Strengthen Documentation and Coding Accuracy: Clear, complete provider documentation ensures accurate code assignment and proper reflection of patient complexity. Proactively Manage Denials and Appeals: Early intervention prevents errors from cascading into distorted data and reduced reimbursement. Align CDI, Coding, and Revenue Cycle with Quality Measures: Collaboration across these functions ensures accurate reporting of outcomes and supports better ratings. Reinforce the Cycle of Accuracy: Accurate documentation leads to improved reimbursement, which enables reinvestment in quality initiatives, ultimately driving higher Star Ratings Connecting Quality and Finance Denial prevention directly supports quality outcomes, enhances reimbursement, and improves patient trust. By managing denials strategically, hospitals turn a traditional operational challenge into an opportunity for growth and leadership in value-based care. Resources: Centers for Medicare & Medicaid Services. (2024). Overall hospital quality star rating. CMS. https://www.cms.gov/medicare/quality/hospital-star-ratings Centers for Medicare & Medicaid Services. (2025). Transforming Episode Accountability Model (TEAM). CMS. https://www.cms.gov/priorities/innovation/innovation-models/team-model Centers for Medicare & Medicaid Services. (2024). Hospital quality star ratings methodology. CMS. https://qualitynet.cms.gov/inpatient/measures/hospital-star-ratings American Hospital Association. (2025). Denials management in hospitals. AHA. https://www.aha.org/topics/denials-management Centers for Medicare & Medicaid Services. (2024). Meaningful Measures 2.0: Moving to measure alignment. CMS. https://www.cms.gov/meaningful-measures-20 American College of Surgeons. (2025). Preparing for TEAM: Transforming Episode Accountability Model
By Katie Curry August 20, 2025
For years, many Clinical Documentation Integrity (CDI) programs have focused heavily on financial metrics like DRG maximization, CC/MCC capture, and CMI shifts. While these numbers can be helpful for spotting trends, benchmarking, and understanding patient populations, they shouldn’t be the sole measure of success. When programs lean too much on these metrics, they risk stalling progress, losing physician engagement, and limiting long-term impact creating a band aid over the larger underlying issues. A stronger, more lasting approach puts clinical accuracy, provider education, and telling the complete patient story at the center, with financial results following naturally from doing the right work. The Limitations of the Traditional Model In a traditional CDI setup, much of the work happens after the fact. Queries go out once documentation is already complete, and success is judged by things like query volume, response rates, and short-term revenue gains. While this can boost the bottom-line short term the moment, it rarely fixes the real documentation gaps. For physicians, this approach often feels like an added layer of administrative work that interrupts their day and adds to compliance fatigue. Despite agreement among many CDI leaders that the focus needs to shift toward clinical understanding and root cause analysis of documentation and quality issues, the revenue-first model still dominates. Financial leaders often focus on revenue KPIs to gauge program performance, but these numbers tell only part of the story. While CDI must ultimately be financially viable, lasting success also depends on accurate reporting, quality outcomes, and better coordination of care. CDI 2.0: Building a Stronger Foundation The CDI 2.0 model focuses on clinical clarity, medical necessity, and improved communication across the care continuum. It blends clear, concise documentation into daily workflows and makes education for providers an ongoing priority formed from partnership with the CDI team. By working this way, documentation is improved at the source rather than adjusted after the fact. When CDI is positioned as a partner in improving patient care, physicians tend to see it as support rather than oversight. The result is documentation that paints a truer picture of the patient’s condition, which improves quality reporting, revenue integrity, patient safety, and collaboration across the care team. Putting Clinical Accuracy at the Core of CDI Organizations that embrace a clinically driven CDI model not only see stronger physician engagement but also achieve more lasting improvements in documentation. This connection is reflected in ACDIS’s Measuring and Valuing Quality survey, where nearly 60% of CDI professionals reported prioritizing Severity of Illness and Risk of Mortality measures ahead of purely financial outcomes. Similarly, the Optimized Comprehensive CDI Programs report found that 73% of respondents identified physician engagement and retention of education as key indicators of success, underscoring that sustainable CDI programs are built on clinical accuracy and provider partnership rather than short-term financial gains. This emphasis on clinical accuracy also extends to quality reporting. The ACDIS CDI and Quality Improvement survey showed that CDI teams track Present on Admission indicators (88%), Patient Safety Indicators (78%), and Hospital-Acquired Conditions (77%), highlighting how documentation accuracy supports organizational quality goals. Lastly, a recent exploratory analysis published in Health Services Research found that hospitals performing better on quality measures such as lower readmission rates, fewer complications, and higher patient satisfaction also tended to report stronger financial results (Carey and Burgess 2023). When CDI programs prioritize accuracy and completeness in the medical record, they not only strengthen clinical quality measures but also support long-term financial stability. Why Accuracy Leads to Better Outcomes As the healthcare landscape continues to evolve, CDI programs that focus on clinical accuracy will be best positioned to adapt and grow. When provider education, quality reporting, and financial performance are aligned around the complete patient story, CDI becomes more than a safeguard for revenue, it becomes a meaningful driver of better care. The future of CDI depends on programs that build physician trust, improve outcomes, and achieve financial stability as the natural result of accurate documentation. Need help transforming your CDI program? UASI offers staffing, assessments, quality audits, education, and more, all designed to elevate documentation accuracy, improve care quality, and uncover sustainable financial gains: https://www.uasisolutions.com/CDI References: ACDIS. Measuring and Valuing Quality. 2021, https://acdis.org/resources/measuring-and-valuing-quality . ACDIS. Optimized Comprehensive CDI Programs. 2023, https://acdis.org/resources/acdis-council-report-optimized-comprehensive-cdi-programs . ACDIS. CDI and Quality Improvement. 2023, https://acdis.org/resources/acdis-council-report-cdi-and-quality-improvement . Carey, Kathleen, and James Burgess. “An Exploratory Analysis of the Association between Hospital Quality Measures and Financial Performance.” Health Services Research, vol. 58, no. 6, 2023, pp. 1242–1252. PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC10606508/ .
By Katie Curry August 6, 2025
Yesterday, the Centers for Medicare & Medicaid Services released several final rules and updates impacting payment and quality expectations for FY 2026. Below is a summary of each announcement and its likely effect on providers across care settings. Quarterly Listing of CMS Program Issuances (April–June 2025) This listing compiles all CMS transmittals, memoranda, manual updates, and other instructions issued in the second quarter of 2025. While not tied to a specific payment update, it sets the compliance and operational agenda that contractors and providers need to follow going into the next fiscal year. Impact: Compliance leaders and revenue cycle teams should review the quarterly listing closely to ensure internal processes reflect the latest guidance on claims processing, provider enrollment, coverage determinations, and survey protocols. Link to announcement: https://www.federalregister.gov/documents/2025/08/05/2025-14822/medicare-and-medicaid-programs-quarterly-listing-of-program-issuances-april-through-june-2025 FY 2026 Hospice Wage Index and Payment Rate Update + Hospice Quality Reporting Program (HQRP) Changes CMS finalized a payment rate increase for hospices along with routine wage index updates. Revisions to HQRP continue the move toward outcome-oriented quality measurement, including preparation for the upcoming HOPE assessment tool. Impact: Hospices should expect modest payment growth coupled with expanded quality reporting expectations that will require stronger documentation and care coordination practices. Link to announcement: https://www.federalregister.gov/documents/2025/08/05/2025-14782/medicare-program-fy-2026-hospice-wage-index-and-payment-rate-update-and-hospice-quality-reporting FY 2026 Inpatient Psychiatric Facility (IPF) PPS Final Rule This rule updates the IPF per diem base rate, wage index, and labor share for FY 2026. CMS also modifies several measures in the IPF Quality Reporting Program to put greater emphasis on behavioral health outcomes and performance improvement. Impact: Psychiatric hospitals and units will see a net payment increase, but must be ready to support enhanced quality tracking and accurate measure reporting to avoid penalties. Link to announcement: https://www.federalregister.gov/documents/2025/08/05/2025-14781/medicare-program-fy-2026-inpatient-psychiatric-facilities-prospective-payment-system-rate-update FY 2026 Inpatient Rehabilitation Facility (IRF) PPS Final Rule IRFs will receive a payment increase in FY 2026 tied to market basket and wage index changes. CMS also continues to strengthen the IRF Quality Reporting Program by refining functional outcome measures and signaling future alignment with post-acute value initiatives. Impact: IRFs should prepare for higher reimbursement alongside increased accountability for quality outcomes and performance on patient assessment data. Link to announcement: https://www.federalregister.gov/documents/2025/08/05/2025-14780/medicare-program-inpatient-rehabilitation-facility-prospective-payment-system-for-federal-fiscal Bottom Line for Providers CMS continues its trend of linking payment updates to quality, transparency, and data integrity. While most settings will enjoy FY 2026 reimbursement increases, each sector should be bracing for greater reporting rigor and operational alignment with value-based objectives. To stay ahead, providers should prioritize internal assessments of their current documentation, coding, and quality reporting workflows to identify any vulnerabilities, considering the new requirements. Investment in education, technology, and cross-functional collaboration will be essential to safeguard compliance, protect revenue, and successfully navigate the evolving value-based landscape.
By Katie Curry July 30, 2025
CMS has identified a group of qualifying APM participants (QPs) from the 2023 performance year whose taxpayer identification numbers (TINs) are either missing or unidentifiable. As a result, CMS is currently unable to disburse the 3.5% APM incentive payments owed for the 2025 payment year. Action Required by September 1, 2025 To avoid forfeiting their incentive payments, affected QPs must: Submit their current Medicare billing information, including TINs, using the instructions provided in a separate notification from CMS. Ensure all relevant Quality Payment Program (QPP) data from the 2023 clinical performance period is submitted by September 1, 2025. Failure to provide the required information by the deadline will result in forfeiture of the APM incentive payment for the 2023 performance year. CMS has made a list of impacted QPs available and is urging all clinicians who expected to receive an APM incentive payment but have not yet received it to verify their status and submit the necessary documentation. Processing Timeline CMS will begin processing all timely submissions after the September 1 deadline. The validation and verification process may take up to three months before payments are issued. HIM leaders should take note because missed incentive payments can result in a significant loss of expected revenue, potentially up to 3.5% per qualifying clinician . Ensuring timely submission of TINs and quality data helps protect the organization’s reimbursement and supports compliance with value-based care initiatives. Proactively coordinating with clinicians and billing teams now can prevent revenue disruptions and strengthen your organization's performance under future APM reporting cycles. For questions, providers can contact the QPP Help Desk at 1-866-288-8292. To view the complete notice please visit: https://www.federalregister.gov/documents/2025/07/30/2025-14434/medicare-program-alternative-payment-model-apm-incentive-payment-advisory-for-clinicians-request-for

Stay ahead in healthcare with UASI’s monthly newsletter—your source for expert insights, regulatory updates, and proven strategies that drive clinical and financial success. Each issue delivers real-world case studies, tips for navigating coding and compliance changes, and the latest tools to support your team.


Subscribe today to stay informed and empowered in a fast-changing healthcare landscape.

HCC RISK ADJUSTMENT 
V24 - V28

Are You Ready?

Ensuring your organization makes a successful transition

Learn about the changes and implications of the HCC model transition from V24 to V28, featuring industry experts in medical coding and CDI. We will discuss the changes and implications of the HCC model transition from V24 to V28 and gain actionable insights on navigating challenges, optimizing workflows, and ensuring accurate risk scoring under the new model.

Understanding that risk adjustment is not just HCC but is underlying in everything we do in mid revenue.

Provider Queries 101
Article Download

Accurate documentation isn't just about getting the diagnosis right...

it's about optimizing reimbursement, meeting quality metrics, and delivering the best possible care.

Download the Provider Queries 101 article to learn how better documentation practices can have a significant impact on your organization's bottom line.

Explore UASI's comprehensive resource page for valuable insights, tools, and expertise in healthcare staffing, revenue cycle management, and compliance solutions

By Katie Curry September 7, 2025
What does it mean when “neurostorming” is documented? “Neuro storm” and other similar terms such as autonomic storms, hypothalamic dysregulation syndrome and sympathetic storms all equate to the condition paroxysmal sympathetic hyperactivity (PSH). This syndrome was formally named in 2014 by an international panel looking at preferred nomenclature, definition and diagnostic criteria. PSH is defined as a disorder in the regulation of autonomic function most observed in patients with acute brain injury, most notably severe traumatic brain injury. What are the risk factors for PSH? Traumatic brain injury (TBI) Hypoxic ischemic injury What are the clinical indicators of PSH? Sinus tachycardia Elevated systolic blood pressure Tachypnea associated with respiratory alkalosis Diaphoresis that can progress to dehydration Hyperthermia in some cases Severe cases may have dystonic posturing How is PSH treated? Reducing stimulation Managing hyperthermia and hyperventilation Medications IV Morphine Gabapentin Beta blockers Baclofen Precedex infusion Dantrolene Coding and CDI considerations for the documentation of “neurostorming” The ICD-10-CM condition code most appropriate for reporting of PSH is G90.89, Other disorders of autonomic nervous system. There is no specific code to identify neurostorm or PSH. There are also no instructional notes for the code G90.89. Per the ICD10-CM Official Coding Guidelines, “ If a main term cannot be located, consider a synonym, an eponym, or another alternative term. Once the main term is located, search for subterms, notes, or cross-references. Subterms provide many types of more specific information and must be checked carefully, following all the rules of alphabetization. The main term code entry should not be assigned until all subterm possibilities have been exhausted. During this process, it may be necessary to refer again to the medical record to determine whether any additional information is available to permit assignment of a more specific code. If a subterm cannot be located, the nonessential modifiers following the main term should be reviewed to see whether the subterm may be included there. If not, alternative terms should be considered” Current coding advice notes that when the index is confusing, leading to an inappropriate code, further research is needed when the title of the code suggested by the index clearly does not identify the condition correctly. Regarding the CDI professional, it is allowable to report code G90.89, Other disorders of autonomic nervous system in the instance where “neurostorm” is documented by the provider. A query would not be needed for clarification. References: American Hospital Association (AHA). ICD-10-CM Coding Clinic, Second Quarter 2025, p. 4. Available from: AHA Coding Clinic Centers for Medicare & Medicaid Services (CMS). (2025). ICD-10-CM Official Guidelines for Coding and Reporting. Available from: CMS ICD-10-CM Guidelines Rabinstein, A. (2024). Paroxysmal sympathetic hyperactivity. UpToDate. Available from: UpToDate – Paroxysmal sympathetic hyperactivity
By Katie Curry August 7, 2025
Background: With the 2026 IPPS Proposed Final Rule comes a new diabetes code, E11.A, Type II diabetes mellitus without complications in remission. This is a non-CC/MCC and is assigned to MDC 10. ICD-10-CM Official Guidelines for Coding and Reporting 2026: Section I.C.4.a.1.(b) - “Code E11.A, Type 2 diabetes mellitus without complications in remission, is assigned based on provider documentation that the diabetes mellitus is in remission. If the documentation is unclear as to whether the Type 2 diabetes mellitus has achieved remission, the provider should be queried. For example, the term “resolved” is not synonymous with remission.” Clinical criteria for diabetes in remission: Note* - Remission does not mean cure. Ongoing monitoring is essential as relapse is possible. 1. Prior Diagnosis of Diabetes Mellitus Documented history of type 2 diabetes mellitus, diagnosed using standard criteria: HbA1c ≥ 6.5% Fasting plasma glucose ≥ 126 mg/dL 2-hour plasma glucose ≥ 200 mg/dL during an OGTT Random plasma glucose ≥ 200 mg/dL with classic symptoms 2. Normal or Controlled Glucose Levels Without Medications The patient is not taking any antidiabetic medications (oral agents, insulin, or non-insulin injectables). Glycemic control is sustained through lifestyle modifications, such as diet and exercise. HbA1c < 6.5%, and sometimes < 6.0%, on two occasions at least 6 months apart without pharmacologic therapy. 3. Duration of Remission Partial remission: HbA1c < 6.5% and fasting glucose 100–125 mg/dL for at least 1 year without medications. Complete remission: HbA1c in the normal range (<5.7%) and fasting glucose <100 mg/dL for at least 1 year. Prolonged remission: Complete remission lasting ≥5 years. 4. Documentation Must Include Clear statement that diabetes is in remission or resolution. No current use of diabetes medications. Current HbA1c values. Lifestyle interventions being used. Absence of ongoing diabetic complications (or if present, they are noted as sequelae) 5. What about Type I diabetes? Is remission associated? “Honeymoon Phase” vs. Remission Some individuals newly diagnosed with type 1 diabetes may experience a "honeymoon phase": This is a temporary period (weeks to months) where insulin needs to decrease and blood glucose levels may normalize. However, this is not true remission, as the autoimmune process continues and insulin dependence eventually returns. Clinical Scenario Dr. Doctor, Documentation in your visit note indicates the patient has a documented history of type 2 diabetes mellitus, but current labs show: HbA1c: 5.6% No diabetes medications (e.g., insulin, metformin) currently prescribed Patient reports lifestyle changes (e.g., diet and weight loss) No hyperglycemia documented during this admission or recent visits Query Based on the clinical picture, can you please clarify the patient’s current diabetic status? ☐ Type 2 diabetes mellitus – continue to document and treat as active ☐ History of type 2 diabetes mellitus, currently in remission (no medications, normal glucose values) ☐ Other: ________________ References: American Diabetes Association. Standards of Care in Diabetes—2024: Section 2 and Section 6. 2024. Section 2: https://pubmed.ncbi.nlm.nih.gov/38078586/ Full guidelines: https://professional.diabetes.org/standards-of-care Section 6: https://diabetesjournals.org/care/article/47/Supplement_1/S111/153951/6-Glycemic-Goals-and-Hypoglycemia-Standards-of PMC version: https://pmc.ncbi.nlm.nih.gov/articles/PMC10725808/ Buse, John B., et al. “How Do We Define Cure of Diabetes?” Diabetes Care, vol. 32, no. 11, 2009, pp. 2133–2135. DOI: 10.2337/dc09-9036. PubMed: https://pubmed.ncbi.nlm.nih.gov/19875608/ PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC2768219/ Centers for Medicare & Medicaid Services. ICD-10-CM Official Guidelines for Coding and Reporting 2026. 2025. https://www.cms.gov Centers for Medicare & Medicaid Services. IPPS 2026 Proposed Final Rule. 2025. https://www.cms.gov
By Katie Curry July 9, 2025
Definition: Neonatal encephalopathy (NE) is a clinically defined syndrome of disturbed neurologic function in the earliest days of life in a term or late preterm infant, manifested by difficulty with initiating and maintaining respiration, depression of tone and reflexes, subnormal level of consciousness, and often seizures. Clinical presentation: Low APGAR scores and/or weak/absent cry in the delivery room. Hyperalert, irritable, lethargic, obtunded. Decreased spontaneous movements, poor tone, blunted or absent primitive reflexes, seizure activity. Breathing and/or feeding difficulties. Documentation Tips: The CDS should review to identify the underlying etiology . (e.g., hypoxic-ischemic event, infection, metabolic disorder). Review clinical indicators that may indicate associated conditions , such as seizures, abnormal imaging, acidosis, or multi-organ dysfunction. Review the documentation for the timing of onset (e.g., at birth, delayed). Common clinical indicators include low APGAR scores, need for resuscitation, abnormal tone, or altered level of consciousness.  ICD-10-CM Coding: P91.811, Neonatal encephalopathy in diseases classified elsewhere P91.819, Neonatal encephalopathy, unspecified Use when the type or etiology of NE is not documented Query Example: To the Attending Neonatologist: Documentation in the medical record indicates the newborn infant delivered from mother with placental abruption demonstrates seizures, abnormal muscle tone, low APGAR scores, and required resuscitation at birth. Imaging showed evidence of cerebral edema. The diagnosis of “neonatal encephalopathy” was documented in the assessment. Query: Based on the clinical indicators, can you clarify the type and cause of the encephalopathy in this newborn? Please select the most appropriate option below or specify another diagnosis: Neonatal encephalopathy due to Hypoxic-ischemic encephalopathy (HIE) Neonatal encephalopathy due to other etiology (please specify) Other (please specify): __________
By Katie Curry May 12, 2025
Definition: Tumor lysis syndrome (TLS) is an oncologic emergency caused by massive tumor cell lysis and the release of large amounts of potassium, phosphate, and uric acid into the systemic circulation. Deposition of uric acid and/or calcium phosphate crystals in the renal tubules can result in acute kidney injury.
Show More

Stay ahead with UASI Coding Tips section, featuring practical advice, industry updates, and best practices to enhance your coding accuracy and efficiency.

By Katie Curry September 9, 2025
With CMS’s push towards greater clinical granularity and documentation specificity, the FY 2026 ICD-10-CM Coding Guidelines, which go into effect October 1, 2025, introduces over 487 new diagnosis codes, revises 38, and deletes 28 codes. This is nearly doubling the volume of new codes over FY 2025. One of those major changes involves how coders select and sequence human immunodeficiency virus (HIV) codes. These changes to the guidelines, in section I.C.1.a.2, include various scenarios involving patients before, during, and after an HIV diagnosis. I.C.1.a.2(a) tells you to assign B20 Human immunodeficiency virus [HIV] disease when physician documentation indicates the patient has acquired immunodeficiency syndrome (AIDS), HIV, “or if the patient is treated for any HIV-related illness or is described as having any condition(s) resulting from the patient’s HIV positive status.” I.C.1.a.2(c) adds clarification that you can assign B20 as a secondary diagnosis for patients with HIV who have been admitted “for an unrelated condition (such as a traumatic injury).” Per the guideline revision, the same is now going to be true for “other documented conditions.” I.C.1.a.2(e) clarifies use of Z21 Asymptomatic human immunodeficiency virus [HIV] infection status. You are told to apply the code when, “‘HIV positive,’ ‘HIV test positive,’ or similar terminology is documented, and there is no documentation of symptoms or HIV-related illness.” I.C.1.a.2(f) still tells you to assign R75 Inconclusive laboratory evidence of human immunodeficiency virus [HIV] for patients with inconclusive serology of HIV; however, the language “but no definitive diagnosis or manifestations of the illness” has been deleted. Patients previously diagnosed with HIV continue to assign B20, but now the diagnosis will have to be documented and not “previously known,” per guideline revision. I.C.1.a.2(h) tells you to assign O98.7 Human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium only “when a patient presents during pregnancy, childbirth or the puerperium with documented symptomatic HIV disease or an HIV related illness.” Also assign Z21 for pregnant patients, patients giving birth, and for patients during the puerperium who are either HIV-positive or who have documented asymptomatic HIV. I.C.1.a.2(i), the language changes from “If a patient is being seen to determine his/her HIV status,” to “If a patient without signs or symptoms is tested for HIV.” Additionally, for patients with signs and symptoms presenting for testing, you are now told not to report Z11.4 Encounter for screening for human immunodeficiency virus [HIV]. I.C.1.a.2(j) provides revised instructions for reporting HIV-positive patients who are being treated with an antiretroviral medication. In FY 2026, assign Z21 “in the absence of any additional documentation of HIV disease, HIV-related illness or AIDS.” Practical Application Documentation specificity is critical Look for exact terms (“HIV positive,” “AIDS,” “HIV disease,” “asymptomatic HIV”). Query if unclear. Sequence by admission reason HIV-related = B20 as principal. Unrelated dx = that condition is principal and B20 secondary. Never revert from B20 Once HIV-related illness is documented, always use B20 on future encounters. Apply pregnancy rules Use O98.7 first, then B20 or Z21 based on symptoms/illness. Add management/prevention codes Use Z79.899 for antiretrovirals Z29.81 for PrEP (pre-exposure prophylaxis); any risk factors should also be coded. References Centers for Medicare & Medicaid Services. (2025, October 1). FY 2026 ICD‑10‑CM official guidelines for coding and reporting [PDF]. U.S. Department of Health and Human Services. Retrieved from: CMS.gov American Academy of Professional Coders. (2025, June 16). Coding update: FY 2026 ICD‑10‑CM official guidelines released. AAPC. Retrieved from: aapc.com
By Katie Curry September 5, 2025
Kerecis, is the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration. In total, nearly 200 million people in the United States are now covered under commercial insurance plans that recognize fish skin grafts as medically necessary for chronic wound care. According to the Kerecis website, this graft “promotes healing with minimal impairment of functionality and positive cosmetic outcomes. The product is homologous to human skin and when applied to damaged tissue such as burns or wounds, helps top support the body’s own cells to regenerate tissue.” Coding Clinic has released official guidance regarding Kerecis graft application in the fourth quarter of 2024. Their guidance tells us to report this application as replacement of skin with nonautologous tissue, full thickness, external approach. ( ICD-10-CM/PCS Coding Clinic, Fourth Quarter ICD-10 2024 Page: 65) CMS has released an LCD regarding the covered diagnosis for this unique skin regeneration. This procedure requires a dual diagnosis requirement. When reporting E08.621, E09.621, E10.621, E11.621, E13.621, one of the following must be reported with it to identify the site and severity of the ulcer : L97.411, L97.412, L97.415, L97.416, L97.421, L97.422, L97.511, L97.512, L97.515, L97.516, L97.521, L97.522, L97.525, or L97.526. References: American Hospital Association. (2024). ICD-10-CM/PCS coding clinic, fourth quarter 2024 (Vol. 11, No. 4, p. 65). Chicago, IL: American Hospital Association. Centers for Medicare & Medicaid Services. (n.d.). Local Coverage Determination (LCD): Skin substitute grafts/cellular and tissue-based products for the treatment of diabetic foot ulcers and venous leg ulcers (L36377). U.S. Department of Health and Human Services. Retrieved September 5, 2025, from https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=36377 Centers for Medicare & Medicaid Services. (n.d.). Article: Billing and coding: Skin substitute grafts/cellular and tissue-based products for the treatment of diabetic foot ulcers and venous leg ulcers (A57680). U.S. Department of Health and Human Services. Retrieved September 5, 2025, from https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=57680 Kerecis. (n.d.). Intact fish skin for tissue regeneration. Kerecis. Retrieved September 5, 2025, from https://www.kerecis.com
By Katie Curry September 4, 2025
Hypoglossal Nerve Stimulant placement is mainly used to treat obstructive sleep apnea. This is a surgically implanted device that stimulates the nerves that move the tongue and open the airway while a person sleeps. This device is recommended when a CPAP device is not tolerable. As of 2023, the only hypoglossal nerve stimulator that is approved by the Food and Drug Administration is the Inspire device. Parts to the System Include : Breathing monitor, Pulse generator, Electrode(s), Hand-held remote control Two Different Models *Inspire IV: three implantable components – the Inspire device, a stimulation lead and a respiratory sensing lead *Inspire V: (newer version) eliminates the separate respiratory sensing lead, resulting in a simpler two-component system. Covered by most insurances, however commercial insurances may only cover the procedure for people with BMI of 32 or less. For Medicare there is a dual diagnosis requirement: G47.33 Obstructive Sleep Apnea (adult)(pediatric) BMI code (Z68.1-Z68.34) Corresponding CPT’s: 64582 – Implant Inspire IV or 64568 – Implant Inspire V 64583 – Revision/Replacement of breathing & nerve stimulator electrodes 64584 – Removal of device (electrodes & generator) 61885 - Revisions from Inspire IV to Inspire V 61886 - Generator replacement with connection to 2 or more electrodes * Append modifier 52 in instances where only a portion of the device listed in the description is revised/removed (e.g., revision of breathing sensor lead only or revision of stimulation lead only) Practical Application Confirm payer coverage, especially BMI limits for commercial plans. Review the operative note to determine if the full device or only a component was revised (use modifier 52 if partial). Select the correct CPT based on Inspire model (IV vs. V). For Medicare, always include both OSA and BMI codes. Sources: Tampa General Hospital. (2025, June). Tampa General Hospital and USF Health among first U.S. sites to offer new Inspire V system for treating obstructive sleep apnea. Tampa General Hospital News. https://www.tgh.org/news/tgh-press-releases/2025/june/tgh-and-usf-health-among-first-us-sites-to-offer-new-inspire-v-system Karen Zupko & Associates, Inc. (2025, August 14). Coding for Inspire. KZA Coding Coaches. https://www.kzanow.com/coding-coaches/coding-for-inspire-8-14-25 Johns Hopkins Medicine. (n.d.). Hypoglossal nerve stimulation implant for sleep apnea. Johns Hopkins Medicine Health. https://www.hopkinsmedicine.org/health/conditions-and-diseases/obstructive-sleep-apnea/hypoglossal-nerve-stimulation
By Katie Curry August 26, 2025
CMS has released the FY 2026 ICD-10-CM October 1st updates ushering in the annual set of updates to diagnosis codes used across all care settings. While there are hundreds of changes, a handful are expected to have an outsized effect on reimbursement, case mix index, quality reporting, and value-based payment programs. Below are the most consequential areas and how organizations should prepare.
Show More

Sign up to receive monthly CDI & Coding Tips directly to your inbox!

Now Hiring Remote Healthcare Roles

Join UASI and make an impact from home with flexible, stable, and well-supported career opportunities.

CDI Specialist (RN) · CDI Auditor · CDI Second Level Reviewer · Coding Manager · Senior Inpatient Coder · OP Profee Coder · ED Remote Coder




Apply Now!

Are you ready
to take the next steps?

Apply now and let's see if it's a good fit!

UASI is an Equal Opportunity/Affirmative Action Employer

OPEN POSITIONS